← Back to Search

Behavioral Intervention

Group Intervention for Insomnia

N/A
Waitlist Available
Led By Whitney L Brown, Psy.D
Research Sponsored by Michael Debakey Veterans Affairs Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 20 weeks
Awards & highlights

Study Summary

Many combat Veterans suffer from posttraumatic stress disorder (PTSD), an anxiety disorder that develops after an extremely stressful event or events. PTSD is associated with problems falling asleep or staying asleep. Veterans with PTSD also commonly have nightmares from stressful experiences. These symptoms can cause problems in daily life. Behavioral treatments that do not involve taking medication have been shown to help improve problems related to sleep and nightmares. However, very few of these treatments address both sleep problems and nightmares at the same time, even though many people suffer from both problems. The purpose of this study is to examine the effectiveness of a combined treatment for sleep problems and nightmares in Veterans suffering from combat-related PTSD that is presented in a group format. The investigators hypothesize that the completion of this treatment will lead to increases in sleep quality and decreases in the frequency and severity of nightmares as measured by standard questionnaires.

Eligible Conditions
  • Insomnia
  • Nightmares
  • Post-Traumatic Stress Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 20 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 20 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Nightmare Effects Survey
Pittsburgh Sleep Quality Index, with Addendum for PTSD
Posttraumatic Stress Disorder Checklist- Stressor Specific Version
Secondary outcome measures
Clinician Administered PTSD Scale

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group InterventionExperimental Treatment1 Intervention
Subjects randomly assigned to this arm of the study will receive the 9-week insomnia and nightmare intervention group once per week for 90 minutes in addition to continuing treatment as usual with medical and mental health providers.
Group II: Treatment as UsualActive Control1 Intervention
This group is randomly assigned to receive only treatment as usual and does not receive the active intervention of the insomnia and nightmare group treatment. This treatment will be made available to these members once the study is completed

Find a Location

Who is running the clinical trial?

Michael Debakey Veterans Affairs Medical CenterLead Sponsor
14 Previous Clinical Trials
345 Total Patients Enrolled
1 Trials studying Insomnia
32 Patients Enrolled for Insomnia
Michael E. DeBakey VA Medical CenterLead Sponsor
64 Previous Clinical Trials
15,758 Total Patients Enrolled
1 Trials studying Insomnia
32 Patients Enrolled for Insomnia
Whitney L Brown, Psy.DPrincipal InvestigatorMichael E. DeBakey VA Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025